Rectum
4
1
1
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
6 treatments under study, led by Total Mesorectal Excision For Rectal Cancer
Research Leaders
8 sponsors active, led by Memorial Sloan Kettering Cancer Center
Related Conditions
Often studied with 9 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 4 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (4)
Comparative Research Between Swenson and Soave Operations for Pediatric Patients Who Have Hirschsprung Disease
The Sexual Health of Rectal Cancer Patients
Long-term Cohort Study of Mesorectal Excision for Rectal Cancer
Pilot Evaluation of 124I-Iodo-Azomycin Galacto-Pyranoside (*IAZGP) Positron Emission Tomography (PET) in the Imaging of Hypoxic Tumors
Research Network
Common Treatments
- Total Mesorectal Excision For Rectal Cancer1
- Csish Cancer Survivorship Intervention1
- Soave Procedure Includes Resection Of The Aganglionic Segment And Anastomosis With Submucosal Thickness Layer Above The Dentate1
- 124iiodoazomycin Galactopyranoside1
- Swenson Operation Includes Resection Of The Aganglionic Segment And Anastomosis With Full Thickness Layer Above The Dentate1
Active Sponsors
- Memorial Sloan Kettering Cancer Center2
- Albert Einstein College of Medicine1
- Kantonsspital Winterthur KSW1
- M.D. Anderson Cancer Center1
- National Institutes of Health (NIH)1
Top Investigators
Memorial Sloan Kettering Cancer Center
Kantonsspital Winterthur KSW
Memorial Sloan Kettering Cancer Center
Related Conditions
- Cervical Cancer1
- Hirschprungs Disease1
- Renal Cancer1
- Cervix Uteri Nos1
- Cancer1